We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Law Offices of Howard G. Smith announces that it is investigating whether Allion Healthcare, Inc.'s ("Allion" or the "Company") (NASDAQ: ALLI) directors complied with their...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Allion Healthcare, Inc. (“Allion” or the “Company”...
Attorney Advertising. Notice is hereby given that Stull, Stull & Brody has commenced an investigation on behalf of shareholders of Allion Healthcare, Inc. (“Allion” or the...
Attorney Advertising. The law firm of Wolf Haldenstein Adler Freeman & Herz LLP is investigating possible breaches of fiduciary duty by the Board of Directors of Allion...
Levi & Korsinsky is investigating the Board of Directors of Allion Healthcare, Inc. (“Allion” or the “Company”) (NasdaqGM: ALLI) for possible breaches of fiduciary duty and...
Allion Healthcare, Inc. (NASDAQ: ALLI) today announced that it has entered into a definitive merger agreement for the Company to be acquired and taken private by an affiliate of...
ORLANDO, FL -- (Marketwire) -- 09/30/09 -- Galea Life Sciences, Inc., maker of Nutraplete(TM) therapeutic drink mix and a pioneer in the field of therapeutic nutrition, today announced that it...
Allion Healthcare (NASDAQ: ALLI): Second Quarter Highlights Net sales increased 15.3% to $100 million from $86 million Specialty HIV net sales increased 9.4% to $75...
Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it has entered into a partnership with Being Alive San Diego to launch a Community Learning Center in San Diego...
Allion Healthcare, Inc. (NASDAQ: ALLI), today announced that it will release its financial results for the second quarter ended June 30, 2009, after the close of U.S. financial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions